Product Information

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG is a generic product labeled by Endo USA Inc., priced at $1.1484 per EA under NDC 49884078809. Its NADAC has been published 485 times since Mar 15, 2017.

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
$1.1484per EA

Strength

5; 25; 40 mg/1; mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884078809

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206137

On Market Since

10/26/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG has been published 485 times since Mar 15, 2017, and over the history we have for it it has declined 64.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1484 per EA
All-time high$3.4602 (Apr 12, 2017)
All-time low$1.0188 (Jul 20, 2022)
52-week high$1.4407
52-week low$1.1009
Median price$1.7434
Average price$1.8313
Largest weekly change+37.5% (Sep 22, 2021)
Weeks tracked485
Tracking sinceMar 15, 2017

Price History

1W

0.0%

1M

-10.4%

3M

-4.7%

6M

-2.8%

1Y

-20.3%

3Y

-17.5%

5Y

-37.5%

All

-64.5%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG?

The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG, manufactured by Endo USA Inc., is $1.1484 per EA (NDC 49884078809), effective Jun 24, 2026.

How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG changed over time?

Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG has declined 64.5%. It has been tracked across 485 weekly CMS publications since Mar 15, 2017.

What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG?

Since Mar 15, 2017, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG has ranged from a low of $1.0188 (Jul 20, 2022) to a high of $3.4602 (Apr 12, 2017), with a median of $1.7434 per EA.

Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG, but none are currently priced below it.

Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG?

OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG (NDC 49884078809) is labeled by Endo USA Inc., and CMS classifies it as a generic product.